Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
出版年份 2019 全文链接
标题
Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
作者
关键词
-
出版物
Cancers
Volume 11, Issue 7, Pages 981
出版商
MDPI AG
发表日期
2019-07-15
DOI
10.3390/cancers11070981
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan
- (2019) Ippei Matsumoto et al. PANCREATOLOGY
- Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients
- (2019) Fleur van der Sijde et al. Cancers
- CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
- (2019) Letizia Porcelli et al. Cancers
- Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
- (2019) Changhoon Yoo et al. Cancers
- Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019
- (2019) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer
- (2019) Elena Rangelova et al. ANNALS OF SURGERY
- FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre
- (2019) Claudia Pouypoudat et al. DIGESTIVE AND LIVER DISEASE
- Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience
- (2019) Luigi Cavanna et al. OncoTargets and Therapy
- Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarcinoma: An AGEO multicentric retrospective cohort
- (2019) Hampig Kourie et al. Clinics and Research in Hepatology and Gastroenterology
- Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
- (2018) Georgios Gemenetzis et al. ANNALS OF SURGERY
- Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
- (2018) Suguru Yamada et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer
- (2018) Jacob E. Shabason et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection
- (2018) Giovanni Marchegiani et al. EUROPEAN RADIOLOGY
- FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study
- (2018) Mustafa Suker et al. JOURNAL OF SURGICAL ONCOLOGY
- Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer
- (2018) Marco Del Chiaro et al. HPB
- Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis
- (2018) Alex Barenboim et al. EJSO
- Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer
- (2018) Jongchan Lee et al. MEDICINE
- Association of Modified‐FOLFIRINOX‐Regimen‐Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population
- (2018) Xiang Li et al. ONCOLOGIST
- Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with gemcitabine/nab-paclitaxel: Results of a retrospective analysis
- (2017) AnaFernández Montes et al. Journal of Cancer Research and Therapeutics
- The role of stromal cancer-associated fibroblasts in pancreatic cancer
- (2017) Dagny von Ahrens et al. Journal of Hematology & Oncology
- Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience.
- (2017) G Lakatos et al. PATHOLOGY & ONCOLOGY RESEARCH
- Locally Advanced Pancreatic Cancer
- (2016) Thilo Hackert et al. ANNALS OF SURGERY
- Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
- (2016) Steffi J. Rombouts et al. ANNALS OF SURGICAL ONCOLOGY
- Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
- (2016) Stacey M Stein et al. BRITISH JOURNAL OF CANCER
- CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma
- (2016) Mathilde Wagner et al. EUROPEAN RADIOLOGY
- Neoadjuvant nab-paclitaxel and gemcitabine (AG) in borderline resectable (BR) or unresectable (UR) locally advanced pancreatic adenocarcinoma (LAPC) in patients ineligible for FOLFIRINOX.
- (2016) Shawn Peterson et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer
- (2016) W. L. Shaib et al. ONCOLOGIST
- Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
- (2016) Nicola Silvestris et al. OncoTargets and Therapy
- Neoadjuvant Therapy for Localized Pancreatic Cancer
- (2015) Douglas B. Evans et al. ANNALS OF SURGERY
- Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
- (2015) Cristina R. Ferrone et al. ANNALS OF SURGERY
- FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
- (2015) Eran Sadot et al. ANNALS OF SURGICAL ONCOLOGY
- Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience
- (2015) Ulrich Nitsche et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability
- (2015) Ronica H. Nanda et al. JOURNAL OF SURGICAL ONCOLOGY
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- FOLFIRINOX-Based Neoadjuvant Therapy in Borderline Resectable or Unresectable Pancreatic Cancer
- (2015) Fausto Petrelli et al. PANCREAS
- Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma
- (2015) Moh'd Khushman et al. PANCREATOLOGY
- Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
- (2014) Marlo Blazer et al. ANNALS OF SURGICAL ONCOLOGY
- Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
- (2014) T Golan et al. BRITISH JOURNAL OF CANCER
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma
- (2014) Hye Chung et al. Journal of Translational Medicine
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience
- (2013) J. E. Faris et al. ONCOLOGIST
- A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
- (2012) Peter J Hosein et al. BMC CANCER
- FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
- (2012) Krishna S. Gunturu et al. MEDICAL ONCOLOGY
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
- (2011) Patrick J. Loehrer et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study
- (2008) B. Chauffert et al. ANNALS OF ONCOLOGY
- Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer
- (2008) Timothy M. Pawlik et al. ANNALS OF SURGICAL ONCOLOGY
- Effect of Hospital Volume on Margin Status after Pancreaticoduodenectomy for Cancer
- (2008) Karl Y. Bilimoria et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now